Fulcrum Therapeutics Announces 2024 Annual Meeting of Stockholders on June 17

TL;DR

<b>Fulcrum Therapeutics will convene its 2024 Annual Meeting of Stockholders virtually on June 17, 2024, to elect directors and ratify auditors.</b>

AI Summary

Fulcrum Therapeutics, Inc. (FULC) filed a Proxy Statement (DEF 14A) with the SEC on April 19, 2024. Fulcrum Therapeutics will hold its 2024 Annual Meeting of Stockholders virtually on June 17, 2024. Stockholders of record as of April 18, 2024, are entitled to vote at the meeting. Key agenda items include the election of three Class II directors: James Collins, James Geraghty, and Alex Sapir. The appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2024 will be ratified. Registration to attend the virtual meeting is required by June 16, 2024, at 11:59 p.m. ET.

Why It Matters

For investors and stakeholders tracking Fulcrum Therapeutics, Inc., this filing contains several important signals. The meeting's virtual format requires advance registration, potentially impacting stockholder participation if deadlines are missed. The election of directors and ratification of auditors are standard corporate governance procedures crucial for company oversight and financial reporting integrity.

Risk Assessment

Risk Level: low — Fulcrum Therapeutics, Inc. shows low risk based on this filing. The filing is a routine proxy statement for an annual meeting, with no immediate financial or operational changes indicated, thus posing low risk.

Analyst Insight

Stockholders should review the nominated directors and auditor ratification to make informed voting decisions.

Key Numbers

• June 17, 2024 — Annual Meeting Date (2024 Annual Meeting of Stockholders)
• April 18, 2024 — Record Date (Stockholders entitled to vote)
• June 16, 2024 — Registration Deadline (Virtual meeting registration)
• 2027 — Director Term Expiration (Class II directors' terms)

Key Players & Entities

• Fulcrum Therapeutics, Inc. (company) — Registrant
• James Collins (person) — Nominated Director
• James Geraghty (person) — Nominated Director
• Alex Sapir (person) — Nominated Director
• Ernst & Young LLP (company) — Independent Registered Public Accounting Firm

FAQ

Risk Factors

• Compliance with SEC Regulations [low — regulatory]: The company must comply with all SEC regulations regarding proxy solicitations and annual meetings.
• Virtual Meeting Logistics [low — operational]: Ensuring smooth technical execution of the virtual meeting and adequate stockholder access and participation.

Key Dates

• 2024-06-17: 2024 Annual Meeting of Stockholders — Key date for voting on director elections and auditor ratification.
• 2024-04-18: Record Date — Determines which stockholders are eligible to vote.
• 2024-06-16: Registration Deadline — Deadline for stockholders to register for the virtual meeting.

Glossary

DEF 14A

Definitive Proxy Statement filed with the SEC. (Standard filing for annual meetings, providing information to shareholders for voting.)

Proxy Statement

A document filed by a company with the SEC that contains information that the shareholders need to vote at a shareholder meeting. (Essential for shareholders to understand the proposals and make informed voting decisions.)

Class II Directors

Directors elected for a specific term, typically three years, in a staggered board structure. (Relates to the election of directors and the composition of the board.)

Key Financial Figures

• $25,000 — n of proxies for a fee of approximately $25,000, plus reimbursement of certain costs an
• $700 million — that is held by non-affiliates exceeds $700 million as of any June 30 before that time or i
• $1.235 billion — or if we have annual gross revenues of $1.235 billion or more in any fiscal year, we would ce
• $1 billion — ng growth company if we issue more than $1 billion of non-convertible debt over a three-ye

Filing Documents

• d735513ddef14a.htm (DEF 14A) — 386KB
• g735513g01g01.jpg (GRAPHIC) — 287KB
• g735513g02g02.jpg (GRAPHIC) — 113KB
• g735513g03k01.jpg (GRAPHIC) — 29KB
• g735513g34p02.jpg (GRAPHIC) — 59KB
• 0001193125-24-102863.txt (&nbsp;) — 1049KB

From the Filing

DEF 14A 1 d735513ddef14a.htm DEF 14A DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240. 14a-12 FULCRUM THERAPEUTICS, INC. (Name of Registrant as Specified in Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 Table of Contents 26 Landsdowne Street Cambridge, Massachusetts 02139 NOTICE OF 2024 ANNUAL MEETING OF STOCKHOLDERS To Be Held on June 17, 2024 Dear Stockholders: You are cordially invited to virtually attend the 2024 annual meeting of stockholders, or the Annual Meeting, of Fulcrum Therapeutics, Inc. The Annual Meeting will be held via the Internet at a virtual audio web conference at www.proxydocs.com/FULC on Monday, June 17, 2024 at 9:00 a.m., Eastern time. Only stockholders who owned shares of our common stock at the close of business on April 18, 2024 are entitled to notice of and to vote at the Annual Meeting or any adjournment thereof. At the Annual Meeting, the stockholders will consider and vote on the following matters: 1. Election of three Class II directors, James Collins, James Geraghty, and Alex Sapir, nominated by our board of directors, each to serve for a three-year term expiring at the 2027 annual meeting of stockholders; 2. Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024; and 3. Transaction of any other business that may properly come before the Annual Meeting or any adjournment or postponement thereof. The Annual Meeting will be a virtual meeting of stockholders, which will be conducted exclusively via the Internet at a virtual web conference. There will not be a physical meeting location, and stockholders will not be able to attend the Annual Meeting in person. This means that you can attend the Annual Meeting online, vote your shares during the online meeting and submit questions during and shortly before the online meeting. In order to attend the meeting and vote your shares electronically during the meeting, you must register in advance at www.proxydocs.com/FULC prior to the deadline of Sunday, June 16, 2024 at 11:59 p.m., Eastern time. Upon completing your registration, you will receive further instructions via email, including your unique links that will allow you to attend the Annual Meeting, vote your shares and submit questions. We believe that hosting a virtual meeting will enable greater stockholder attendance and participation from any location around the world. You can find more information, including the nominees for director, in the proxy statement for the Annual Meeting, which is available for viewing, printing and downloading at www.proxydocs.com/FULC. The board of directors recommends that you vote FOR each of the Class II directors (Proposal 1), and FOR the ratification of the appointment of the proposed independent registered public accounting firm (Proposal 2) as outlined in the attached proxy statement. We are pleased to comply with the rules of the Securities and Exchange Commission, or SEC, that allow companies to distribute their proxy materials over the Internet under the notice and access approach. As a result, we are sending to our stockholders a Notice of Internet Availability of Proxy Materials, or the Notice of Availability, instead of a paper copy of this proxy statement and our annual report for the fiscal year ended December 31, 2023, or the 2023 Annual Report. We will mail the Notice of Availability on or about April 24, 2024, and the Notice of Availability contains instructions on how to access our proxy materials over the Internet. The Notice of Availability also contains Table of Contents instructions on how each of our stockholders can receive a paper copy of our proxy materials, including the proxy statement, our 2023 Annual Report, and a form of proxy card. Your vote is important regardless of the number of shares you own. Whether or not you expect to virtually attend the Annual Meeting online, please vote your shares to ensure your representation and the presence of a quorum at the Annual Meeting. If you are a stockholder of record, you may vote your shares prior to the Annual Meeting on the Internet by visiting www.proxypush.com/FULC, by telephone by ca

View Full Filing

View this DEF 14A filing on SEC EDGAR